phentermine or glp-1 Rapid Medical Weight Loss in

Xtandis patent is expected to expire in 2027

Professional society guidelines (e.g., Endocrine Society and American Urological Association) emphasize testosterone replacement therapy only for men with confirmed biochemical and clinical testosterone deficiency, reinforcing that testosterone should not be positioned as a general adjunct to weight loss or body recomposition in eugonadal men [19,35]

[DOI] [PubMed] [Google Scholar] 71.Yoneda S, Uno S, Iwahashi H, Fujita Y, Yoshikawa A, Kozawa J, Okita K, Takiuchi D, Eguchi H, Nagano H, Imagawa A, Shimomura I

Therapeutic considerations Maximal effect seen within 1015 days Adverse effects include allergic reactions, lacrimation, conjunctivitis and salivary gland pain Key prescribing point Iodide is used as a shortterm adjunct , and longterm use should be avoided due to loss of antithyroid efficacy